Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VIIDiana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al.|Journal of Clinical Oncology|2000Cited by 295
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?Stefan Aebi, Aron Goldhirsch, Shari Gelber et al.|The Lancet|2000Cited by 286
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxelDiana Crivellari, Aron Goldhirsch, Markus Borner et al.|Annals of Oncology|2001Cited by 151
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXStefan Aebi, Aron Goldhirsch, Zijie Sun et al.|Annals of Oncology|2011Cited by 55